Literature DB >> 16211404

[Cerebral secondary prevention--clopidogrel alone or in combination with ASS].

S Nitschmann1, H-P Hartung, M Siebler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16211404     DOI： 10.1007/s00108-005-1507-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  4 in total

1.  European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

Authors:  H C Diener; L Cunha; C Forbes; J Sivenius; P Smets; A Lowenthal
Journal:  J Neurol Sci       Date:  1996-11       Impact factor: 3.181

2.  Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.

Authors:  Hugh S Markus; Dirk W Droste; Manfred Kaps; Vincent Larrue; Kennedy R Lees; Mario Siebler; E Bernd Ringelstein
Journal:  Circulation       Date:  2005-04-25       Impact factor: 29.690

3.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 4.  Resistance to antiplatelet therapy.

Authors:  Sasidhar Guthikonda; Eli I Lev; Neal S Kleiman
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931
  4 in total
  1 in total

1.  Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.

Authors:  Imama A Naqvi; Ayeesha K Kamal; Hasan Rehman
Journal:  Cochrane Database Syst Rev       Date:  2020-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.